PR Newswire - China NMPA approves Simcere's Sanbexin® sublingual...
NANJING, China, Dec. 4, 2024 /PRNewswire/ -- On November 2, 2024, Simcere Pharmaceutical announced that Sanbexin® sublingual tablets (generic name: edaravone and dexborneol sublingual tablets), an inn...
Read More

ภาษาไทย
English